About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
Thymosin Beta-4 Research Guide Complete deep dive into TB-4 mechanisms, dosing, and cardiac research Ipamorelin vs GHRP-2 vs GHRP-6 If you're also exploring growth hormone peptides GHK-Cu Another healing peptide often stacked with BPC-157 for skin and collagen repair LL-37 Antimicrobial peptide with wound healing properties This article is for educational and research purposes only
However, it significantly elevates cortisol and prolactin, creating metabolic complications
10.3109/17453679808999268 35 FortinC
However, many users transition to a lower, maintenance dose after achieving their primary goal to save money and sustain results
